Opus Genetics, Inc. Defined Contribution Plan, Cost
Opus Genetics, Inc. (IRD) reported Defined Contribution Plan, Cost of $7.84 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2020-10-29
- Opus Genetics, Inc. defined contribution plan, cost for the quarter ending 2020-09-30 was $7.84K, a 52.06% decline year-over-year.
- Opus Genetics, Inc. defined contribution plan, cost for the quarter ending 2020-06-30 was $9.79K, a 47.13% decline year-over-year.
- Opus Genetics, Inc. defined contribution plan, cost for the quarter ending 2020-03-31 was $11.23K, a 59.72% decline year-over-year.
- Opus Genetics, Inc. defined contribution plan, cost for the quarter ending 2019-12-31 was $8.83K, a 57.67% decline year-over-year.
- Opus Genetics, Inc. defined contribution plan, cost for fiscal 2019 was $71.57K, a 40.64% decline from fiscal 2018.
- Opus Genetics, Inc. defined contribution plan, cost for fiscal 2018 was $120.56K, a 2.10% decline from fiscal 2017.
- Opus Genetics, Inc. defined contribution plan, cost for fiscal 2017 was $123.14K, a 8.78% increase from fiscal 2016.
- Opus Genetics, Inc. defined contribution plan, cost for fiscal 2016 was $113.20K, a 6.84% decline from fiscal 2015.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 9 month as first filed | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $7.84K 10-Q · filed 2020-10-29 | $17.63K derived: sum of 2 quarters · filed 2020-10-29 | $28.85K 10-Q · filed 2020-10-29 | $37.68K derived: sum of 4 quarters · filed 2020-10-29 | |
| 2020-06-30 | $9.79K 10-Q · filed 2020-08-14 | $21.01K 10-Q · filed 2020-08-14 | $29.84K derived: sum of 3 quarters · filed 2020-08-14 | $46.20K derived: sum of 4 quarters · filed 2020-10-29 | |
| 2020-03-31 | $11.23K 10-Q · filed 2020-05-07 | $20.06K derived: sum of 2 quarters · filed 2020-05-07 | $36.41K derived: sum of 3 quarters · filed 2020-10-29 | $54.92K derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-12-31 | $8.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $25.18K derived: sum of 2 quarters · filed 2020-10-29 | $43.69K derived: sum of 3 quarters · filed 2020-10-29 | $71.57K 10-K · filed 2020-02-21 | |
| 2019-09-30 | $16.36K 10-Q · filed 2020-10-29 | $34.86K derived: sum of 2 quarters · filed 2020-10-29 | $62.74K 10-Q · filed 2020-10-29 | $83.60K derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | $18.51K 10-Q · filed 2020-08-14 | $46.38K 10-Q · filed 2020-08-14 | $67.24K derived: sum of 3 quarters · filed 2020-08-14 | $96.67K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $27.88K 10-Q · filed 2020-05-07 | $48.73K derived: sum of 2 quarters · filed 2020-05-07 | $78.16K derived: sum of 3 quarters · filed 2020-05-07 | $112.63K derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $20.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $50.28K derived: sum of 2 quarters · filed 2020-02-21 | $84.75K derived: sum of 3 quarters · filed 2020-02-21 | $120.56K 10-K · filed 2020-02-21 | |
| 2018-09-30 | $29.43K 10-Q · filed 2019-11-06 | $63.89K derived: sum of 2 quarters · filed 2019-11-06 | $99.70K 10-Q · filed 2019-11-06 | $130.64K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $34.47K 10-Q · filed 2019-08-07 | $70.28K 10-Q · filed 2019-08-07 | $101.22K derived: sum of 3 quarters · filed 2019-08-07 | $132.67K derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | $35.81K 10-Q · filed 2019-05-10 | $66.75K derived: sum of 2 quarters · filed 2019-05-10 | $98.20K derived: sum of 3 quarters · filed 2019-05-10 | $132.81K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $30.94K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $62.40K derived: sum of 2 quarters · filed 2019-03-07 | $97.00K derived: sum of 3 quarters · filed 2019-03-07 | $123.14K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $31.45K 10-Q · filed 2018-11-02 | $66.06K derived: sum of 2 quarters · filed 2018-11-02 | $92.20K 10-Q · filed 2018-11-02 | $102.54K 10-Q · filed 2017-11-03 | $123.54K derived: sum of 4 quarters · filed 2018-11-02 |
| 2017-06-30 | $34.61K 10-Q · filed 2018-08-03 | $71.08K 10-Q · filed 2018-08-03 | $92.08K derived: sum of 3 quarters · filed 2018-08-03 | $121.20K derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $36.48K 10-Q · filed 2018-05-04 | $57.48K derived: sum of 2 quarters · filed 2018-05-04 | $86.59K derived: sum of 3 quarters · filed 2018-05-04 | $118.18K derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $50.12K derived: sum of 2 quarters · filed 2018-03-09 | $81.70K derived: sum of 3 quarters · filed 2018-03-09 | $113.20K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $29.11K 10-Q · filed 2017-11-03 | $60.70K derived: sum of 2 quarters · filed 2017-11-03 | $92.20K 10-Q · filed 2017-11-03 | $115.57K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | $31.59K 10-Q · filed 2017-08-04 | $63.09K 10-Q · filed 2017-08-04 | $86.45K derived: sum of 3 quarters · filed 2018-03-09 | $120.45K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | $31.50K 10-Q · filed 2017-05-03 | $54.87K derived: sum of 2 quarters · filed 2018-03-09 | $88.86K derived: sum of 3 quarters · filed 2018-03-09 | $123.66K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | $23.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $57.36K derived: sum of 2 quarters · filed 2018-03-09 | $92.16K derived: sum of 3 quarters · filed 2018-03-09 | $121.52K 10-K · filed 2018-03-09 | |
| 2015-09-30 | $34.00K 10-Q · filed 2016-11-04 | $68.80K derived: sum of 2 quarters · filed 2016-11-04 | $98.16K 10-Q · filed 2016-11-04 | $119.54K derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-06-30 | $34.80K 10-Q · filed 2016-08-05 | $64.16K 10-Q · filed 2016-08-05 | $85.54K derived: sum of 3 quarters · filed 2017-02-24 | $110.11K derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-03-31 | $29.36K 10-Q · filed 2016-05-06 | $50.74K derived: sum of 2 quarters · filed 2017-02-24 | $75.32K derived: sum of 3 quarters · filed 2017-02-24 | $99.90K derived: sum of 4 quarters · filed 2017-02-24 | |
| 2014-12-31 | $21.38K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $45.96K derived: sum of 2 quarters · filed 2017-02-24 | $70.54K derived: sum of 3 quarters · filed 2017-02-24 | $91.24K 10-K · filed 2017-02-24 | |
| 2014-09-30 | $24.57K 10-Q · filed 2015-11-02 | $49.16K derived: sum of 2 quarters · filed 2015-11-02 | $69.86K 10-Q · filed 2015-11-02 | $88.26K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $24.58K 10-Q · filed 2015-08-07 | $45.28K 10-Q · filed 2015-08-07 | $63.69K derived: sum of 3 quarters · filed 2016-03-14 | $85.52K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $20.70K 10-Q · filed 2015-05-08 | $39.10K derived: sum of 2 quarters · filed 2016-03-14 | $60.94K derived: sum of 3 quarters · filed 2016-03-14 | $81.47K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $18.40K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $40.24K derived: sum of 2 quarters · filed 2016-03-14 | $60.77K derived: sum of 3 quarters · filed 2016-03-14 | $78.49K 10-K · filed 2016-03-14 | |
| 2013-09-30 | $21.84K 10-Q · filed 2014-11-12 | $42.37K derived: sum of 2 quarters · filed 2014-11-12 | $60.08K 10-Q · filed 2014-11-12 | $73.22K derived: sum of 4 quarters · filed 2014-11-12 | |
| 2013-06-30 | $20.53K 10-Q · filed 2014-08-13 | $38.25K 10-Q · filed 2014-08-13 | $51.39K derived: sum of 3 quarters · filed 2014-08-13 | $67.59K derived: sum of 4 quarters · filed 2014-08-13 | |
| 2013-03-31 | $17.72K 10-Q · filed 2014-05-14 | $30.86K derived: sum of 2 quarters · filed 2014-05-14 | $47.06K derived: sum of 3 quarters · filed 2014-05-14 | $64.94K derived: sum of 4 quarters · filed 2014-05-14 | |
| 2012-12-31 | $13.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $29.35K derived: sum of 2 quarters · filed 2014-03-21 | $47.22K derived: sum of 3 quarters · filed 2014-03-21 | $65.69K 10-K · filed 2014-03-21 | |
| 2012-09-30 | $16.21K 10-Q · filed 2013-11-13 | $34.08K derived: sum of 2 quarters · filed 2013-11-13 | $52.55K 10-Q · filed 2013-11-13 | $67.83K derived: sum of 4 quarters · filed 2013-11-13 | |
| 2012-06-30 | $17.87K 10-Q · filed 2013-08-12 | $36.34K 10-Q · filed 2013-08-12 | $51.62K derived: sum of 3 quarters · filed 2013-08-12 | $69.53K derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | $18.46K 10-Q · filed 2013-05-09 | $33.75K derived: sum of 2 quarters · filed 2013-05-09 | $51.65K derived: sum of 3 quarters · filed 2013-05-09 | $67.78K derived: sum of 4 quarters · filed 2013-05-09 | |
| 2011-12-31 | $15.29K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $33.19K derived: sum of 2 quarters · filed 2013-03-22 | $49.32K derived: sum of 3 quarters · filed 2013-03-22 | $66.16K 10-K · filed 2013-03-22 | |
| 2011-09-30 | $17.90K 10-Q · filed 2012-11-08 | $34.03K derived: sum of 2 quarters · filed 2012-11-08 | $50.88K 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $16.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $32.97K 10-Q · filed 2012-08-08 | |||
| 2011-03-31 | $16.85K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |